Exploring the emergence of agentic ecosystems in transforming data accessibility and ensuring reliable answers reach the people making decisions while there is still a choice to make.
|Articles|May 12, 2015
Pharm Exec 2013 Emerging Pharma Leader Appointed CEO, PaxVax
Author(s)Julian Upton
May 11, 2015.
Advertisement
PaxVax, Inc. (Redwood City, CA), a specialty vaccine company focused on travel and biodefense, has appointed Nima Farzan Chief Executive Officer and President.
In 2013, as PaxVax's then Executive Vice President and Chief Operating Officer, Farzan was featured as one of Pharm Exec's Emerging Pharma Leaders. (
Advertisement
Related to this article
A passing FDA inspection tells pharma senior leadership very little about whether the next significant revenue vulnerability is already taking shape. But continuous, AI-enabled quality management maturity (QMM) has the potential to do so months before the issue reaches the realm of P&L.
Why purpose is becoming the most important infrastructure in AI-driven health care technology.
Trialbee CEO Matt Walz explores the current impact of AI in delivering practical gains in clinical development and reflects on its future potential, where enrollment predictability may be the biggest prize of all.
The future of engagement won’t be defined by how much information reaches health care professionals, but by how precisely it supports the decision at hand.
Advertisement
Advertisement
Trending on PharmExec
1
Viatris Acquires Pacira BioSciences for $1.65 Billion
2
Ultragenyx to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million
3
Before You Sign with a New Hub Vendor, Ask These Four Questions
4
ESC 2026: GLP-1–Based Therapies Move Further into Mainstream Cardiovascular Care
5